SPOTLIGHT: Prexige gets the boot in UK, Germany

Drug regulators in the UK, Germany, and Austria have suspended Novartis' license to sell Prexige, an arthritis drug linked to possible liver damage. Report | Report

Suggested Articles

Compared with the FDA "boxed warning," the EMA version puts a smaller restriction on the higher dose but broadens the cautionary language.

Shionogi's newest antibiotic Fetroja has now earned the FDA's approval, but will a mortality-rate warning scuttle the drug's chances?

Novartis' Sandoz doubled down in Japan as Lupin retreated. Dr. Reddy's posted a loss tied to its Zantac recall. Aslan's varlitinib failed again.